Users Discontinuing Weight-Loss Medications Regain Pounds Far More Rapidly Compared to Those on Conventional Diets

A recent study indicates that people who stop using popular weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who end traditional diet and exercise regimens.

Published data in a major medical journal points out that while obese people can lose substantial amounts of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month upon discontinuation.

"People using such medications must be cognizant of the danger of fast rebound weight gain when the therapy concludes," cautioned researcher Dr. Susan Jebb.

This pace of recovery suggests a reversion to starting mass within about one and a half years.

Weighing Therapies

The study, which reviewed dozens of trials involving over 9,000 of patients, compared the effects of the injectable medications with older methods.

Scientists note that people who shed pounds through diet and exercise generally see a slower weight regain—perhaps 0.1 kg a month—post-intervention.

Explaining the Quick Rebound

Experts believe the mode of action of the jabs accounts for the accelerated weight return.

The injections mimic a natural hormone called GLP-1, which moderates appetite.

"Long-term administration of the hormone levels far above than normal might result in the body to produce less of its own natural hormone, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics researcher.

"Withdrawal of this medication leads to hunger is uncontrolled, making binge eating far more likely."

An Ongoing Disease?

Health authorities advise the injections for people with obesity-related medical conditions, accompanied by recommended lifestyle changes.

A number of clinicians say that, due to the likelihood of weight regain, the treatment should be considered ongoing.

This opinion is echoed by pharmaceutical companies, who say that the results "underscore the long-term nature of excess weight," comparing it to managing conditions like diabetes.

Patient Experiences

People who have stopped the jabs report a powerful return of hunger.

"I experienced something that goes on and I was suddenly ravenous," recalled an individual.

The struggle is exacerbated if users have not developed sustainable lifestyle or habit modifications during treatment.

Significant Adoption

Figures suggest that a significant number of people in the UK have tried these injections in the last 12 months, with interest being substantial.

• Use is higher among females compared to men.
• The 40s and 50s demographic shows the highest level of interest.
• Many obtain the medications through private healthcare rather than public health services.

In conclusion, researchers emphasize that while these medications are effective agents for shedding pounds, they are not a permanent cure and lasting health benefits relies on combined behavioural support.